Leserbrief
Explanation Regarding Questions About an AAF
Drug Testing and Analysis · 2026-05 · 18 (5) · 643-645
DOI: 10.1002/dta.70059 ↗Kurz gefasst
Leserbrief in der Zeitschrift Drug Testing and Analysis, online erschienen am 10.03.2026. Verfasst von Jean-Claude Alvarez und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, Inserm U-1018, CESP, Teams MOODS, Paris-Saclay/Versailles University, Garches, France.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Pharmacology and Toxicology, Inserm U-1018, CESP, Teams MOODS, Paris-Saclay/Versailles University, Garches, France.
- Exed, CentraleSupelec, Paris-Saclay University, Gif-sur-Yvette, France.
ORCID-Profile: Jean-Claude Alvarez
Zitieren
APA
Alvarez, J. C., & Dine, G. (2026). Explanation Regarding Questions About an AAF. Drug Testing and Analysis, 18(5), 643-645. https://doi.org/10.1002/dta.70059
Vancouver
Alvarez JC, Dine G. Explanation Regarding Questions About an AAF. Drug Testing and Analysis. 2026;18(5):643-645. doi:10.1002/dta.70059
BibTeX
@article{Alvarez2026,
author = {Alvarez, Jean-Claude and Dine, Gérard},
title = {Explanation Regarding Questions About an AAF},
journal = {Drug Testing and Analysis},
year = {2026},
volume = {18},
number = {5},
pages = {643--645},
doi = {10.1002/dta.70059}
}
EUVIMED